Identification and antimicrobial susceptibility profiles of Nocardia species clinically isolated in Japan.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 08 2021
Historique:
received: 23 12 2020
accepted: 02 08 2021
entrez: 19 8 2021
pubmed: 20 8 2021
medline: 12 11 2021
Statut: epublish

Résumé

The aims of the present study were to profile the antimicrobial susceptibility patterns of a diverse range of Nocardia species isolated in Japan, and to determine the ability of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for species/complex identification. Identification of 153 clinical isolates was performed by full-length 16S rRNA gene sequencing as a reference method to evaluate the usefulness of MALDI-TOF MS identification. Antimicrobial susceptibility testing (AST) for 14 antibiotics was performed using the broth microdilution method against 146 of the isolates. Among the total 153 clinical isolates, Nocardia farcinica complex (25%) was the most common species, followed by Nocardia cyriacigeorgica (18%), Nocardia brasiliensis (9%), Nocardia nova (8%), and Nocardia otitidiscaviarum (7%). Among 150 isolates identified to the species/complex level by 16S rRNA gene sequencing, MALDI-TOF MS with the use of a supplemental Nocardia library (JMLD library ver.ML01) correctly identified 97.3% (n = 146) to the species/complex level and 1.3% (n = 2) to the genus level. Among the 146 Nocardia isolates that underwent AST, the susceptibilities were 100% to linezolid, 96% to amikacin, 94% to trimethoprim-sulfamethoxazole, and 76% to imipenem. None of the trimethoprim-sulfamethoxazole-resistant isolates carried either plasmid-mediated sulfonamide-resistant genes (sul1, sul2) or trimethoprim-resistant genes (dfrA).

Identifiants

pubmed: 34408177
doi: 10.1038/s41598-021-95870-2
pii: 10.1038/s41598-021-95870-2
pmc: PMC8373947
doi:

Substances chimiques

RNA, Bacterial 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16742

Informations de copyright

© 2021. The Author(s).

Références

Antimicrob Agents Chemother. 2014;58(2):795-800
pubmed: 24247124
J Clin Microbiol. 2010 Nov;48(11):4015-21
pubmed: 20861335
Antimicrob Agents Chemother. 1995 Feb;39(2):279-89
pubmed: 7726483
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
Mayo Clin Proc. 2012 Apr;87(4):403-7
pubmed: 22469352
Antimicrob Agents Chemother. 2015;59(6):3263-70
pubmed: 25801559
Antimicrob Agents Chemother. 2003 Mar;47(3):1169-72
pubmed: 12604565
J Clin Microbiol. 2017 Dec 26;56(1):
pubmed: 29118169
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2013;24(1):1-8
pubmed: 24800394
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11030-5
pubmed: 15258291
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Front Microbiol. 2015 Apr 28;6:376
pubmed: 25972856
Clin Microbiol Infect. 2021 Apr;27(4):550-558
pubmed: 33418019
Clin Microbiol Rev. 2016 Apr;29(2):401-27
pubmed: 26960941
Appl Environ Microbiol. 2009 Feb;75(3):559-66
pubmed: 19047381
Jpn J Antibiot. 1988 May;41(5):523-9
pubmed: 3216474
Microbiol Insights. 2015 Sep 22;8:15-23
pubmed: 26448688
J Infect Chemother. 2013 Feb;19(1):128-37
pubmed: 23263188
J Bacteriol. 2008 Feb;190(3):834-42
pubmed: 17905979
J Clin Microbiol. 2012 Apr;50(4):1270-80
pubmed: 22219309
Antimicrob Agents Chemother. 2005 Feb;49(2):836-9
pubmed: 15673783
J Clin Microbiol. 2015 Feb;53(2):713-5
pubmed: 25411172
Transpl Infect Dis. 2018 Aug;20(4):e12902
pubmed: 29668123
Clin Proteomics. 2015 Mar 07;12(1):6
pubmed: 25931991
Antimicrob Agents Chemother. 2018 Jun 26;62(7):
pubmed: 29686152
Clin Microbiol Rev. 2006 Apr;19(2):259-82
pubmed: 16614249
J Antimicrob Chemother. 2005 Sep;56(3):470-80
pubmed: 16040625
J Clin Microbiol. 2008 Apr;46(4):1178-84
pubmed: 18256227
Jpn J Antibiot. 1987 Feb;40(2):349-56
pubmed: 3648153
Clin Pharmacol. 2014 Sep 26;6:139-48
pubmed: 25298740
J Clin Microbiol. 2015 Oct;53(10):3366-9
pubmed: 26269617
J Clin Microbiol. 2007 Feb;45(2):529-35
pubmed: 17135443
Infect Chemother. 2013 Mar;45(1):62-8
pubmed: 24265951
Antimicrob Agents Chemother. 2011 May;55(5):2084-91
pubmed: 21343461
Clin Infect Dis. 2016 Aug 1;63(3):338-45
pubmed: 27090987
Appl Environ Microbiol. 2011 May;77(9):3052-60
pubmed: 21378035
J Clin Microbiol. 2014 Jul;52(7):2371-9
pubmed: 24759706
PLoS Pathog. 2020 Mar 5;16(3):e1008280
pubmed: 32134995
Clin Microbiol Infect. 2019 Apr;25(4):489-495
pubmed: 29933049
J Clin Microbiol. 2016 May;54(5):1251-8
pubmed: 26912758

Auteurs

Masahiro Toyokawa (M)

Preparing section for New Faculty of Medical Science, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Japan. toyokawa@fmu.ac.jp.
Department of Laboratory Medicine, Fukushima Medical University, Fukushima, Japan. toyokawa@fmu.ac.jp.
Department of Clinical Laboratory Medicine, Fukushima Medical University Hospital, Fukushima, Japan. toyokawa@fmu.ac.jp.

Noboru Ohana (N)

Department of Laboratory Medicine, Fukushima Medical University, Fukushima, Japan.

Akiko Ueda (A)

Laboratory for Clinical Investigation, Osaka University Hospital, Osaka, Japan.

Minako Imai (M)

Department of Clinical Laboratory Medicine, Fukushima Medical University Hospital, Fukushima, Japan.

Daiki Tanno (D)

Department of Laboratory Medicine, Fukushima Medical University, Fukushima, Japan.
Department of Clinical Laboratory Medicine, Fukushima Medical University Hospital, Fukushima, Japan.

Mutsuko Honda (M)

Department of Clinical Laboratory Medicine, Fukushima Medical University Hospital, Fukushima, Japan.

Yukiko Takano (Y)

Department of Clinical Laboratory Medicine, Fukushima Medical University Hospital, Fukushima, Japan.

Kazutaka Ohashi (K)

Department of Clinical Laboratory Medicine, Fukushima Medical University Hospital, Fukushima, Japan.

Kyoichi Saito (K)

Department of Laboratory Medicine, Fukushima Medical University, Fukushima, Japan.

Hiroki Shimura (H)

Department of Laboratory Medicine, Fukushima Medical University, Fukushima, Japan.
Department of Clinical Laboratory Medicine, Fukushima Medical University Hospital, Fukushima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH